Coross Biosciences completed an angel round of financing of nearly 10 million yuan to open up the domestic market of chemical proteomics

Recently, Nanjing ChomiX Biotech Co., Ltd., referred to as "Colox Bio", announced the completion of an angel ...

More

Character Interview Chen Nan: Big Brother of the Laboratory, Pioneer in the Industry

Dr. Chen Nan, born in Xinyang City, Henan Province, graduated from the School of Chemistry and ...

More

Chemical proteomics platform Jnana Therapeutics completes US$50 million in Series B financing

Recently, in Boston, Jnana Therapeutics, a biotechnology company, used its next-generation chemical proteomics platfo...

More

• 2021.08.05Bayer interception and Vividion IPO
• 2021.08.02Develop KRAS dual inhibitor! Seven months after "handing in" with AbbVie, this upstart company raised US$88.5 million in Series B financing
• 2021.06.28Vividion Therapeutics: Small molecule drug company targeting transcription factors applies for IPO
• 2021.03.31BridGene Biosciences announced that it has reached a cooperation with Takeda Pharmaceuticals to jointly develop small-molecule drugs for "un-druggable" targets

Colossus Bio, recruiting talents!

Coruosi Biologics based on the cross-field of chemical biology; We are n...

More